Citric Acid

Citric Acid

SCHEMBL3067698

N#Cc1ccc2[nH]ccc2c1.O=C(O)CC(O)(CC(=O)O)C(=O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 1/20 0.40
SLC6A2 known ✓ P23975 3/20 0.38
IMPDH2 P12268 1/20 0.61
IMPDH1 P20839 1/20 0.61
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40
GABRE P78334 1/20 0.40
GABRA6 Q16445 1/20 0.40
GABRG1 Q8N1C3 1/20 0.40
GABRG3 Q99928 1/20 0.40
GABRQ Q9UN88 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL7364790 0.81 IMPDH2 (0.77) IMPDH2IMPDH1GABRPGABRDGABRA1
SCHEMBL30389000 0.78 IMPDH2 (1.00) IMPDH2IMPDH1GABRPGABRDGABRA1
SCHEMBL91366 0.78 IMPDH2 (1.00) IMPDH2IMPDH1GABRPGABRDGABRA1
Maleic Acid SCHEMBL28775310 0.78 IMPDH2 (0.73) IMPDH2IMPDH1GABRPGABRDGABRA1
Fumaric Acid SCHEMBL28775322 0.78 IMPDH2 (0.73) IMPDH2IMPDH1GABRPGABRDGABRA1
Methyl Alcohol SCHEMBL27844152 0.77 IMPDH2 (0.89) IMPDH2IMPDH1GABRPGABRDGABRA1
SCHEMBL28194905 0.77 IMPDH2 (0.96) IMPDH2IMPDH1GABRPGABRDGABRA1
Hydrochloric Acid SCHEMBL27803164 0.77 IMPDH2 (0.96) IMPDH2IMPDH1GABRPGABRDGABRA1
Citric Acid SCHEMBL4763398 0.76 TRPA1 (0.53) CTNNB1WNT3AALDH1A1SLC6A2SLC6A4
SCHEMBL27734695 0.74 IMPDH2 (0.71) IMPDH2IMPDH1GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101772497-A New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate ASTRAZENECA AB 2010-07-07 CN claimed
US-20100267720-A1 Crystalline Forms of 2-Hydroxy-3- [5- (Morpholin- 4- Ylmethyl) Pyridin-2-YL] IH- Indole- 5 -Carbonitrile Citrate ASTRAZENECA AB (SE) 2010-10-21 US disclosed
CN-101772497-A New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate ASTRAZENECA AB 2010-07-07 CN disclosed
CN-101772497-A New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate ASTRAZENECA AB 2010-07-07 CN disclosed
CN-101679353-A A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701 ASTRAZENECA AB 2010-03-24 CN disclosed
WO-2007089193-A1 A PROCESS FOR PREPARING 2-HYDROXY-3- [5- (MORPHOLIN-4-YLMETHYL)PYRIDIN-2-YL] LH-INDOLE-5-CARBONITRILE AS A FREE BASE OR SALTS THEREOF ASTRAZENECA AB (SE) 2007-08-09 WO disclosed